MarketCap
Facebook
X
TelegramQuarterly report 2022-Q3
added 11-02-2022
1Life Healthcare Cash Conversion Cycle 2011-2026 | ONEM
Annual Cash Conversion Cycle 1Life Healthcare
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 39.8 | 56.6 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 56.6 | 39.8 | 48.2 |
Quarterly Cash Conversion Cycle 1Life Healthcare
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 26.8 | - | 34 | - | 37.8 | 33.6 | 40 | 50.9 | 52.3 | 70 | 44.5 | 39.6 | 20.5 | 21.6 | 21.2 | 12.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 70 | 12.6 | 36.1 |
Cash Conversion Cycle of other stocks in the Health information services industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Accolade
ACCD
|
-4.64 | - | 0.29 % | $ 206 M |  USA |
 |
Cerner Corporation
CERN
|
-20 | - | - | $ 27.9 B | USA |
 |
Computer Programs and Systems
CPSI
|
43.2 | - | 4.4 % | $ 133 M | USA |
 |
Covetrus
CVET
|
52.1 | - | - | $ 2.94 B | USA |
 |
Change Healthcare
CHNG
|
87 | - | - | $ 9.03 B | USA |
 |
Castlight Health, Inc.
CSLT
|
68.7 | - | -7.28 % | $ 227 M | USA |
 |
HMS Holdings Corp.
HMSY
|
-587 | - | - | $ 3.29 B | USA |
 |
Inovalon Holdings, Inc.
INOV
|
56.1 | - | - | $ 6.37 B | USA |
 |
iCAD
ICAD
|
117 | - | - | $ 102 M | USA |
 |
HealthEquity
HQY
|
21.5 | $ 86.04 | 1.79 % | $ 7.41 B | USA |
 |
Evolent Health
EVH
|
183 | $ 2.84 | -5.02 % | $ 266 M | USA |
 |
GoodRx Holdings
GDRX
|
-124 | $ 2.27 | -3.4 % | $ 876 M | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
71 | - | -10.39 % | $ 886 M | USA |
 |
Akerna Corp.
KERN
|
-5.62 | - | - | $ 161 M | USA |
 |
MTBC
MTBC
|
42.2 | - | -0.58 % | $ 51.7 M | USA |
 |
NextGen Healthcare
NXGN
|
37.1 | - | - | $ 1.6 B | USA |
 |
10x Genomics
TXG
|
167 | $ 26.08 | 3.33 % | $ 3.06 B | USA |
 |
Health Catalyst
HCAT
|
44.4 | $ 1.32 | 3.94 % | $ 92.3 M | USA |
 |
OptimizeRx Corporation
OPRX
|
125 | $ 7.17 | 7.98 % | $ 123 M | USA |
 |
Premier
PINC
|
110 | - | - | $ 2.33 B | USA |
 |
Schrödinger
SDGR
|
192 | $ 12.34 | 2.32 % | $ 906 M | USA |
 |
Phreesia
PHR
|
21.2 | $ 9.17 | - | $ 548 M | USA |
 |
R1 RCM
RCM
|
21.9 | - | - | $ 3.81 B | USA |
 |
Teladoc Health
TDOC
|
28.2 | $ 5.69 | -2.23 % | $ 1 B | USA |
 |
Signify Health
SGFY
|
214 | - | -0.02 % | $ 7.21 B | USA |
 |
Streamline Health Solutions
STRM
|
59.4 | - | - | $ 21.4 M | USA |
 |
NantHealth
NH
|
-54.1 | - | -46.64 % | $ 10.4 M | USA |
 |
SCWorx Corp.
WORX
|
43.5 | - | - | $ 7.71 M | USA |
 |
American Well Corporation
AMWL
|
84.9 | $ 6.12 | -1.13 % | $ 98.2 M | USA |
 |
Tabula Rasa HealthCare
TRHC
|
12 | - | - | $ 255 M | USA |
 |
HealthStream
HSTM
|
14.1 | $ 21.73 | 1.73 % | $ 660 M | USA |
 |
Omnicell
OMCL
|
112 | $ 38.28 | 1.81 % | $ 1.76 B | USA |
 |
Progyny
PGNY
|
121 | $ 18.12 | 1.06 % | $ 1.55 B | USA |
 |
So-Young International
SY
|
87 | $ 2.83 | 1.07 % | $ 225 M |  China |
 |
Veeva Systems
VEEV
|
114 | $ 167.95 | 0.16 % | $ 27.5 B | USA |
 |
Zhongchao
ZCMD
|
-31 | $ 2.06 | -1.9 % | $ 7.04 M | China |